Loading...
机构名称:
¥ 12.0

% Percent AAV-2 Adeno-associated virus serotype 2 AE Adverse event AHRQ Agency for Healthcare Research and Quality AUC Area under the curve BCVA Best corrected visual acuity BLA Biologics license application CDR Clinical trial Diversity Rating CE Cost-effectiveness CI Confidence interval evLYs Equal value of life years FDA Food and Drug Administration FrACT Freiburg Visual Acuity Test Gc Genome copies Gc/eye Genome copies per eye GDP Gross domestic product HD High-dose HIDI Health Distribution Index IRD Inherited retinal disease IVT Intravitreal treatment LD Low-dose LogMAR Logarithmic minimum angle of resolution LSM Least-squares mean LYs Life years MCO-010 Multi-characteristic opsin mITT Modified intention-to-treat population MLSDT Multi-luminance shape discrimination test MLYMT多亮度y运动测试n数字n总数n/a不适用na nr nr nr nr nr nr nr nr n nr nr n nr n n n n n n drestighos prisma均可用于系统评价和荟萃分析的QALY质量质量质量质量质量为rct的随机率很高关心美国美国

SonpireTigene Isteparvovec用于高级视网膜炎的色素:有效性和价值

SonpireTigene Isteparvovec用于高级视网膜炎的色素:有效性和价值PDF文件第1页

SonpireTigene Isteparvovec用于高级视网膜炎的色素:有效性和价值PDF文件第2页

SonpireTigene Isteparvovec用于高级视网膜炎的色素:有效性和价值PDF文件第3页

SonpireTigene Isteparvovec用于高级视网膜炎的色素:有效性和价值PDF文件第4页

SonpireTigene Isteparvovec用于高级视网膜炎的色素:有效性和价值PDF文件第5页

相关文件推荐